Series B-C (scale-up) fund research profile
Fundamentum is a concentrated growth-stage investor for Indian technology companies that have product-market fit and are ready to scale. Its model is built around fewer, larger bets in consumer internet and enterprise software, with founders supported through the transition from startup to durable company.
At a glance
Research profile
Open a section to inspect the evidence. The first view starts with the investment point of view; the rest stays quiet until you need it.
Investment lens
Fundamentum Partnership uses a series b-c (scale-up) approach across Consumer tech, SaaS.
Current evidence
Fundamentum’s Fund III was registered in 2026 and its current platform lists a ₹2,200 crore growth fund with named positions including Wishlink, Apps for Bharat, Genie Mode, Whizzo, FarEye, Probo and Ayu Health.
Strategy
Series B-C (scale-up)
Sector focus
Consumer tech, SaaS
AIF structure context
Indian venture capital and angel-fund strategies are commonly structured as Category I AIFs. Verify the specific vehicle and registration before investing.
Current signal
Fundamentum’s Fund III was registered in 2026 and its current platform lists a ₹2,200 crore growth fund with named positions including Wishlink, Apps for Bharat, Genie Mode, Whizzo, FarEye, Probo and Ayu Health.
Investor questions
Fundamentum Partnership is covered in Rupeia's venture capital research universe. The current public record describes the strategy as Series B-C (scale-up), with a sector focus of Consumer tech, SaaS. The profile should be read with the linked source trail and Typical route: Category I AIF context.
The profile displays only company or asset names attributable to Fundamentum Partnership in the reviewed public sources: PharmEasy, Spinny, TransBnk, Wishlink, Apps for Bharat, Genie Mode, Whizzo, FarEye, Probo, Ayu Health. It does not represent a complete current portfolio unless the manager has published one.
Fund II reporting cites PharmEasy and Spinny as early-growth unicorn outcomes, more than $1B of follow-on capital raised by portfolio companies and a reported 26% gross IRR. Fund III reporting cites a ₹2,200 crore target and ₹100–150 crore cheques; these are manager or media-reported figures, not audited net performance. These signals are not a substitute for fund- and vintage-specific net performance, realised distributions and audited or administrator-supported reporting.
Public fund size: Fund II closed at $227M in 2022. Fund III launched with a ₹2,200 crore target including a ₹400 crore greenshoe option in 2026.. Public terms or access information: Series B and later / early growth, with planned $25–40M leads or co-leads in Fund II and ₹100–150 crore cheques reported for Fund III. The strategy is concentrated rather than high-volume.. Current fees, minimum commitment and availability must be confirmed for the exact named vehicle in its fund documents.
The current source record names Nandan Nilekani, Sanjeev Aggarwal, Ashish Kumar. Verify current roles, departures, attribution and key-person provisions before relying on the team history for a new commitment.
Review stage concentration, follow-on reserves, company failure rates, dilution, exit timing and the gap between paper valuations and realised distributions. The current open diligence point is: Fund III plans.
2026: Fundamentum’s Fund III was registered in 2026 and its current platform lists a ₹2,200 crore growth fund with named positions including Wishlink, Apps for Bharat, Genie Mode, Whizzo, FarEye, Probo and Ayu Health.
Next step
Share the allocation question, ticket size, liquidity constraints and existing exposure. Rupeia can determine whether this profile needs a deeper decision-support brief.